2 QUALITATIVE AND QUANTITATIVE …
New Zealand Data Sheet Buscopan & Buscopan Forte - Hyoscine butylbromide Property of the Sanofi group - strictly confidential buscopan-ccdsv0-dsv3-28jun2018 Page 3
Download 2 QUALITATIVE AND QUANTITATIVE …
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
ENT Emergencies formatted - Ask Doctor Clarke
www.askdoctorclarke.comNotes by Rebecca Exley 2009 www.askdoctorclarke.com 1 ENT Emergencies Foreign bodies 1. Nose Organic Non-organic Battery (requires urgent removal as corrosive)
BUSCOPAN SOLUÇÃO PACIENTE
www.buscopan.com.brBUSCOPAN SOLUÇÃO PACIENTE abcd Buscopan solução_Bula Paciente CCDS 0057-06/S 13-00 1
Guidelines for the management of respiratory …
www.emrpcc.org.auEastern Metropolitan Region Palliative Care Consortium (Victoria) www.emrpcc.org.au Clinical Working Party
Continuous Bladder Irrigation Protocol
www.gbhn.caTitle: Microsoft Word - Continuous_Bladder_Irrigation_Protocol.doc Author: julia.metzger Created Date: 11/27/2007 3:25:02 PM
Buscopan 10 mg Tablets (hyoscine butylbromide) …
www.mhra.gov.ukUKPAR Buscopan 10 mg Tablets PL 00015/0347 1 . Buscopan 10 mg Tablets (hyoscine butylbromide) PL 00015/0347 . UKPAR . …
CT SCAN - PRP Diagnostic Imaging
www.prpimaging.com.auPreparation Information Sheet www.prpimaging.com.au PRP Diagnostic Imaging Pty Ltd ABN: 96 129 790 174 CT SCAN Complications: Allergic reactions to contrast material can occur but significant reactions are rare, and generally respond to
10 mg tablets - Medicines
www.medicines.org.ukPregnancy and breast-feeding Do not take BUSCOPAN Tablets if you are pregnant, likely to get pregnant or are breast-feeding. Driving and using machines